🇺🇸 FDA
Patent

US 9937243

Sialylated glycoprotein compositions and uses thereof

granted A61KA61K38/47A61K45/06

Quick answer

US patent 9937243 (Sialylated glycoprotein compositions and uses thereof) held by Ultragenyx Pharmaceutical Inc. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ultragenyx Pharmaceutical Inc.
Grant date
Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/47, A61K45/06, A61K9/0019, A61P